Danaher Corporation
$236.98
+2.91 · +1.24% today
Market open · updated 12:44:26 PM ET
- High
- $237.35 6:40 AM
- Low
- $236.02 5:30 AM
Against the S&P 500 Price change through Oct 28, 2026
DHR+2.25%
S&P 500+13.26%
DHR+7.92%
S&P 500+12.41%
DHR+24.58%
S&P 500+88.06%
DHR−13.30%
S&P 500+68.51%
Key numbers
- Previous close
- $234.07
- Open
- $234.00
- Day's range
- $232.86 – $237.62
- 52-week range
- $160.93 – $242.80
- Volume
- 1.1 million
- Average volume
- 4.7 million
- Market value
- $166.6 billion
- Price to earnings
- 38.2last 12 months
- Earnings per share
- $6.15last 12 months
- Beta
- 0.80moves less than the market
- Dividend
- $1.52 a year · 0.65%
- 50-day average
- $218.02
- 200-day average
- $201.13
Analyst price targets and the full financials are in the terminal.
Who Danaher competes with From our value chain
Danaher in the news
No desk stories on DHR yet. When we write about it, the story leads this list.
- HeadlineDanaher (DHR) Upgraded to Buy: Here's WhyZacks Investment Research · October 27, 2026 at 1:00 PM ET
- HeadlineLH vs. DHR: Which Stock Is the Better Value Option?Zacks Investment Research · October 22, 2026 at 12:41 PM ET
- HeadlineDanaher Q3 Recap: Decent Results, Still A HoldSeeking Alpha · October 22, 2026 at 7:15 AM ET
- HeadlineWhy Danaher Stock Bounced Higher TodayThe Motley Fool · October 21, 2026 at 5:06 PM ET
- HeadlineDanaher Corporation (DHR) Q3 2026 Earnings Call TranscriptSeeking Alpha · October 21, 2026 at 3:44 PM ET
- HeadlineDanaher: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · October 21, 2026 at 2:20 PM ET
- HeadlineDanaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5.5% Ex-Respiratory as EPS Guidance RisesGuruFocus · October 21, 2026 at 2:01 PM ET
- HeadlineDanaher Q3 Review: Interested To See What The New Management Will BringSeeking Alpha · October 21, 2026 at 1:12 PM ET
Congress trades in DHR
6 purchases and 2 sales in the latest 8 filings.
| Member | Trade | Amount | Traded | Disclosed |
|---|---|---|---|---|
| Kevin HernHouse · R-Oklahoma | Sale | $1,001 - $15,000 | Sep 2, 2026 | Sep 28, 2026 |
| Kevin HernHouse · R-Oklahoma | Sale | $15,001 - $50,000 | Aug 31, 2026 | Sep 28, 2026 |
| Michael McCaulHouse · R-Texas | Purchase | $1,001 - $15,000 | Jun 16, 2026 | Jul 13, 2026 |
| Michael McCaulHouse · R-Texas | Purchase | $1,001 - $15,000 | Jun 5, 2026 | Jul 13, 2026 |
| Michael McCaulHouse · R-Texas | Purchase | $1,001 - $15,000 | Jun 3, 2026 | Jul 13, 2026 |
| Michael McCaulHouse · R-Texas | Purchase | $1,001 - $15,000 | Jun 2, 2026 | Jul 13, 2026 |
| Ro KhannaHouse · D-California | Purchase | $15,001 - $50,000 | Jun 2, 2026 | Jul 8, 2026 |
| Michael McCaulHouse · R-Texas | Purchase | $1,001 - $15,000 | Apr 28, 2026 | May 11, 2026 |
Source: Periodic transaction reports filed with the House and the Senate · Members disclose ranges, not exact amounts, and may file weeks after the trade.
About Danaher
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 59,000
- Headquarters
- Washington, District of Columbia
- Website
- danaher.com
- Listed
- Dec 29, 1978
More medical - diagnostics & research stocks
The price refreshes every 15 seconds while the market is open and carries the time it was read. Company figures are updated each evening. Built from WiseView and market data and public filings. For information only, not investment advice.